NCT06688825 Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program
| NCT ID | NCT06688825 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Virginia Commonwealth University |
| Condition | Kidney Transplant; Complications |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-09-16 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-09-16 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will be a single-arm feasibility study, with a treatment intervention that includes three interrelated components: (1) patient education using a proven weight loss curriculum, and (2) technology tools for making healthy lifestyle choices.
Eligibility Criteria
Inclusion Criteria: * on the waiting list for kidney transplant at VCUHS * BMI greater than 35 kg/m2 Exclusion Criteria: * Children, prisoners, pregnant women
Contact & Investigator
Evan Sisson
PRINCIPAL INVESTIGATOR
Virginia Commonwealth University
Frequently Asked Questions
Who can join the NCT06688825 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Transplant; Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06688825 currently recruiting?
Yes, NCT06688825 is actively recruiting participants. Contact the research team at emsisson@vcu.edu for enrollment information.
Where is the NCT06688825 trial being conducted?
This trial is being conducted at Richmond, United States.
Who is sponsoring the NCT06688825 clinical trial?
NCT06688825 is sponsored by Virginia Commonwealth University. The principal investigator is Evan Sisson at Virginia Commonwealth University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.